medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2019, Número 1

<< Anterior Siguiente >>

Rev Invest Clin 2019; 71 (1)


Respiratory Impact of Electronic Cigarettes and “Low-Risk” Tobacco

Thirión-Romero I, Pérez-Padilla R, Zabert G, Barrientos-Gutiérrez I

Idioma: Ingles.
Referencias bibliográficas: 86
Paginas: 17-27
Archivo PDF: 217.02 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Disease Control Center for Chronic Disease Prevention, Promotion on Smoking. E-Cigarette use among Youth and Young Adults: A Report of the Surgeon General. Rockville, MD: Department of Health Services for Disease; 2016

  2. Chun LF, Moazed F, Calfee CS, Matthay MA, Gotts JE. Pulmonary toxicity of e-cigarettes. Am J Physiol Lung Cell Mol Physiol. 2017;313:L193-206

  3. Monraz-Pérez S, Regalado-Pineda J, Pérez-Padilla R. El cigarro electrónico: peligro u oportunidad. Neumol Cir Torax. 2015; 74:82-6

  4. Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and metaanalysis. Lancet Respir Med. 2016;4:116-28

  5. Barbara D. A high-tech Approach to Getting a Nicotine Fix. The Electronic Cigarette-a Gadget that looks like the Real Thing and Delivers Nicotine Without Smoke-is Established in China, and Companies are Taking aim at the U.S. market. Los Angeles Times; 2009

  6. Herrington JS, Myers C. Electronic cigarette solutions and resultant aerosol profiles. J Chromatogr A. 2015;1418:192-9

  7. Breland A, Soule E, Lopez A, et al. Electronic cigarettes: what are they and what do they do? Ann N Y Acad Sci. 2017;1394:5-30

  8. Williams M, Villarreal A, Bozhilov K, Lin S, Talbot P. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One. 2013; 8:e57987

  9. Czogala J, Goniewicz ML, Fidelus B, et al. Secondhand exposure to vapors from electronic cigarettes. Nicotine Tob Res. 2014; 16:655-62

  10. Flouris AD, Chorti MS, Poulianiti KP, et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol. 2013;25:91-101

  11. Zhang Y, Sumner W, Chen DR. In vitro particle size distributions in electronic and conventional cigarette aerosols suggest comparable deposition patterns. Nicotine Tob Res. 2013;15:501-8

  12. Reidel B, Radicioni G, Clapp PW, et al. E-cigarette use causes a unique innate immune response in the lung, involving increased neutrophilic activation and altered mucin secretion. Am J Respir Crit Care Med. 2018;197:492-501

  13. Cai H, Wang C. Graphical review: the redox dark side of e-cigarettes; exposure to oxidants and public health concerns. Redox Biol. 2017;13:402-6

  14. Callahan-Lyon P. Electronic cigarettes: human health effects. Tob Control. 2014;23 Suppl 2:ii36-40

  15. Dinakar C, O’Connor GT. The health effects of electronic cigarettes. N Engl J Med. 2016;375:1372-81

  16. Schraufnagel DE, Blasi F, Drummond MB, et al. Electronic cigarettes. A position statement of the forum of international respiratory societies. Am J Respir Crit Care Med. 2014;190:611-8

  17. Amato MS, Boyle RG, Levy D. How to define e-cigarette prevalence? Finding clues in the use frequency distribution. Tob Control. 2016;25:e24-9

  18. Stratton K, Kwan LY, Eaton DL. Committee on the Review of the Health Effects of Electronic Nicotine Delivery Systems, Board on Population Health and Public Health Practice, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine. Public Health Consequences of E-Cigarettes. Washington, D.C. National Academies Press; 2018

  19. Biener L, Hargraves JL. A longitudinal study of electronic cigarette use among a population-based sample of adult smokers: association with smoking cessation and motivation to quit. Nicotine Tob Res. 2015;17:127-33

  20. Gravely S, Fong GT, Cummings KM, et al. Awareness, trial, and current use of electronic cigarettes in 10 countries: findings from the ITC project. Int J Environ Res Public Health. 2014; 11:11691-704

  21. Conference of the Parties to the WHO Framework Convention on Tobacco Control. Electronic nicotine delivery systems. FCTC/ COP/6/10 Rev.1; 2014

  22. Thrasher JF, Abad-Vivero EN, Barrientos-Gutíerrez I, et al. Prevalence and correlates of E-cigarette perceptions and trial among early adolescents in Mexico. J Adolesc Health. 2016;58:358-65

  23. Lozano P, Barrientos-Gutierrez I, Arillo-Santillan E, et al. A longitudinal study of electronic cigarette use and onset of conventional cigarette smoking and marijuana use among Mexican adolescents. Drug Alcohol Depend. 2017;180:427-30

  24. Vardavas CI, Filippidis FT, Agaku IT. Determinants and prevalence of e-cigarette use throughout the European Union: a secondary analysis of 26/566 youth and adults from 27 countries. Tob Control. 2015;24:442-8

  25. Levy DT, Yuan Z, Li Y. The prevalence and characteristics of Ecigarette users in the U.S. Int J Environ Res Public Health. 2017;14:10

  26. Secretaría de Salud. ENCODAT Encuesta Nacional de Consumo de Drogas, Alcohol y Tabaco 2016-2017 Reporte de Tabaco; 2017

  27. Instituto Nacional de Salud Pública. Consumo de Nicotina en Alumnos de Secundaria, 2016. Tabaco y cine en América Latina. México: Instituto Nacional de Salud Pública; 2016

  28. Instituto Nacional de Salud Pública. Consumo de Substancias en Alumnos de Secundaria, 2015-2016. Tabaco y cine en América Latina. México: INSP; 2016

  29. East K, Hitchman SC, Bakolis I, et al. The association between smoking and electronic cigarette use in a cohort of young people. J Adolesc Health. 2018;62:539-47

  30. Park SH, Duncan DT, Shahawy OE, et al. Characteristics of adults who switched from cigarette smoking to E-cigarettes. Am J Prev Med. 2017;53:652-60

  31. David K. The Deeming Rule: Vape Shops. Division of Enforcement and Manufacturing Office of Compliance and Enforcement, CTP, FDA; 2016

  32. World Health Organization. WHO Framework Convention on Tobacco Control. Geneva: World Health Organization; 2003

  33. World Health Organization. The Tobacco Industry Documents What they are, What They Tell us, and How to Search Them. A Practical Manual. Geneva, Switzerland: World Health Organization; 2004

  34. U.S Department of Health and Human Services Food and Drug Administration Center for Tobacco Products. Guidance for Industry and FDA Staff. Use of Light, Mild, Low, or Similar Descriptors in the Label, Labeling, or Advertising of Tobacco Products. U.S Department of Health and Human Services Food and Drug Administration Center for Tobacco Products; 2010

  35. Nutt DJ, Phillips LD, Balfour D, et al. Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res. 2014;20:218-25

  36. Hajek P, Etter JF, Benowitz N, Eissenberg T, McRobbie H. Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction. 2014; 109:1801-10

  37. Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf. 2014;5:67-86

  38. Polosa R. E-cigarettes: public health England’s evidence based confusion? Lancet. 2015;386:1237-8

  39. McNeill A, Brose LS, Calder R, Hitchman SC. E-cigarettes: An Evidence Update. London: A Report Commissioned by Public Health England; 2015

  40. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23:133-9

  41. Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L. Nicotine levels in electronic cigarettes. Nicotine Tob Res. 2013; 15:158-66

  42. Hess CA, Olmedo P, Navas-Acien A, et al. E-cigarettes as a source of toxic and potentially carcinogenic metals. Environ Res. 2017;152:221-5

  43. Vansickel AR, Weaver MF, Eissenberg T. Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction. 2012;107:1493-500

  44. Farsalinos KE, Spyrou A, Tsimopoulou K, et al. Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci Rep. 2014;4:4133

  45. Lerner CA, Sundar IK, Yao H, et al. Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PLoS One. 2015;10:e0116732

  46. Higham A, Bostock D, Booth G, Dungwa JV, Singh D. The effect of electronic cigarette and tobacco smoke exposure on COPD bronchial epithelial cell inflammatory responses. Int J Chron Obstruct Pulmon Dis. 2018;13:989-1000

  47. Hom S, Chen L, Wang T, et al. Platelet activation, adhesion, inflammation, and aggregation potential are altered in the presence of electronic cigarette extracts of variable nicotine concentrations. Platelets. 2016;27:694-702

  48. Leigh NJ, Lawton RI, Hershberger PA, Goniewicz ML. Flavourings significantly affect inhalation toxicity of aerosol generated from electronic nicotine delivery systems (ENDS). Tob Control. 2016; 25:ii81-7

  49. Scheffler S, Dieken H, Krischenowski O, et al. Evaluation of Ecigarette liquid vapor and mainstream cigarette smoke after direct exposure of primary human bronchial epithelial cells. Int J Environ Res Public Health. 2015;12:3915-25

  50. Schweitzer KS, Chen SX, Law S, et al. Endothelial disruptive proinflammatory effects of nicotine and e-cigarette vapor exposures. Am J Physiol Lung Cell Mol Physiol. 2015;309:L175-87

  51. Sussan TE, Gajghate S, Thimmulappa RK, et al. Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defenses in a mouse model. PLoS One. 2015; 10:e0116861

  52. Miyashita L, Suri R, Dearing E, et al. E-cigarette vapour enhances pneumococcal adherence to airway epithelial cells. Eur Respir J. 2018;51:1-10.

  53. Garcia-Arcos I, Geraghty P, Baumlin N, et al. Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine- dependent manner. Thorax. 2016;71:1119-29

  54. Benowitz NL. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol. 2009;49:57-71

  55. Narkiewicz K, van de Borne PJ, Hausberg M, et al. Cigarette smoking increases sympathetic outflow in humans. Circulation. 1998;98:528-34

  56. Moheimani RS, Bhetraratana M, Yin F, et al. Increased cardiac sympathetic activity and oxidative stress in habitual electronic cigarette users: implications for cardiovascular risk. JAMA Cardiol. 2017;2:278-84

  57. Qasim H, Karim ZA, Rivera JO, Khasawneh FT, Alshbool FZ. Impact of electronic cigarettes on the cardiovascular system. J Am Heart Assoc. 2017;6:1-14.

  58. Shields PG, Berman M, Brasky TM, et al. A review of pulmonary toxicity of electronic cigarettes in the context of smoking: a focus on inflammation. Cancer Epidemiol Biomarkers Prev. 2017;26:1175-91

  59. Polosa R, Cibella F, Caponnetto P, et al. Health impact of Ecigarettes: a prospective 3.5-year study of regular daily users who have never smoked. Sci Rep. 2017;7:13825

  60. Wieslander G, Norbäck D, Lindgren T. Experimental exposure to propylene glycol mist in aviation emergency training: acute ocular and respiratory effects. Occup Environ Med. 2001; 58:649-55

  61. Polosa R, Russell C, Nitzkin J, Farsalinos KE. A critique of the US surgeon general’s conclusions regarding e-cigarette use among youth and young adults in the United States of America. Harm Reduct J. 2017;14:61

  62. McConnell R, Barrington-Trimis JL, Wang K, et al. Electronic cigarette use and respiratory symptoms in adolescents. Am J Respir Crit Care Med. 2017;195:1043-9

  63. Cho JH, Paik SY. Association between electronic cigarette use and asthma among high school students in South Korea. PLoS One. 2016;11:e0151022

  64. Clapp PW, Jaspers I. Electronic cigarettes: their constituents and potential links to asthma. Curr Allergy Asthma Rep. 2017;17:79

  65. Kumral TL, Saltürk Z, Yildirim G, et al. How does electronic cigarette smoking affect sinonasal symptoms and nasal mucociliary clearance? B-ENT. 2016;12:17-21

  66. Vardavas CI, Anagnostopoulos N, Kougias M, et al. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest. 2012;141:1400-6

  67. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of lung health study participants after 11 years. Am J Respir Crit Care Med. 2002;166:675-9

  68. Kruse GR, Kalkhoran S, Rigotti NA. Use of electronic cigarettes among U.S. Adults with medical comorbidities. Am J Prev Med. 2017;52:798-804

  69. Schweitzer RJ, Wills TA, Tam E, Pagano I, Choi K. E-cigarette use and asthma in a multiethnic sample of adolescents. Prev Med. 2017;105:226-31

  70. Bowler RP, Hansel NN, Jacobson S, et al. Electronic cigarette use in US adults at risk for or with COPD: analysis from two observational cohorts. J Gen Intern Med. 2017;32:1315-22

  71. McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P. Electronic cigarettes for smoking cessation and reduction. Cochrane Database Syst Rev. 2014;1-58:CD010216

  72. Caponnetto P, Campagna D, Cibella F, et al. Efficiency and safety of an electronic cigarette (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One. 2013;8:e66317

  73. Polosa R, Caponnetto P, Morjaria JB, et al. Effect of an electronic nicotine delivery device (e-cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health. 2011;11:786

  74. Bullen C, Howe C, Laugesen M, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013; 382:1629-37

  75. Hartmann-Boyce J, McRobbie H, Bullen C, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2016;9:CD010216

  76. Gulland A. E-cigarettes help smokers quit, cochrane review confirms. BMJ. 2016;354:i4993

  77. Glantz SA, Bareham DW. E-cigarettes: use, effects on smoking, risks, and policy implications. Annu Rev Public Health. 2018; 39:215-35

  78. Primack BA, Soneji S, Stoolmiller M, Fine MJ, Sargent JD. Progression to traditional cigarette smoking after electronic cigarette use among US adolescents and young adults. JAMA Pediatr. 2015;169:1018-23

  79. Singh T, Agaku IT, Arrazola RA, et al. Exposure to advertisements and electronic cigarette use among US middle and high school students. Pediatrics. 2016;137:1-7.

  80. Vasiljevic M, Petrescu DC, Marteau TM. Impact of advertisements promoting candy-like flavoured e-cigarettes on appeal of tobacco smoking among children: an experimental study. Tob Control. 2016;25:e107-12

  81. Bold KW, Kong G, Camenga DR, et al. Trajectories of E-cigarette and conventional cigarette use among youth. Pediatrics. 2018; 141:1-7.

  82. Soneji S, Barrington-Trimis JL, Wills TA, et al. Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults: a systematic review and meta-analysis. JAMA Pediatr. 2017;171:788-97

  83. Corey CG, Ambrose BK, Apelberg BJ, King BA. Flavored tobacco product use among middle and high school students-United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64:1066-70

  84. Dai H, Hao J. Flavored electronic cigarette use and smoking among youth. Pediatrics. 2016;138:1-8.

  85. Food and Drug Administration, HHS. Deeming tobacco products to be subject to the federal food, drug, and cosmetic act, as amended by the family smoking prevention and tobacco control act; restrictions on the sale and distribution of tobacco products and required warning statements for tobacco products. Final rule. Fed Regist. 2016;81:28973-9106

  86. Brown J, Beard E, Kotz D, Michie S, West R. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction. 2014;109: 1531-40




2020     |     www.medigraphic.com